{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:19:01Z","timestamp":1790835541681,"version":"4.1.0"},"reference-count":290,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.neuropharm.2015.05.031","type":"journal-article","created":{"date-parts":[[2015,6,7]],"date-time":"2015-06-07T00:56:00Z","timestamp":1433638560000},"page":"4-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":187,"special_numbering":"C","title":["An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration"],"prefix":"10.1016","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8152-7979","authenticated-orcid":false,"given":"Geoffrey","family":"Burnstock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2015.05.031_bib1","series-title":"Purinergic Approaches in Experimental Therapeutics","first-page":"383","article-title":"ATP in brain function","author":"Abbracchio","year":"1997"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1254\/jjp.78.113","article-title":"Purinergic signalling: pathophysiological roles","volume":"78","author":"Abbracchio","year":"1998","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.tins.2008.10.001","article-title":"Purinergic signalling in the nervous system: an overview","volume":"32","author":"Abbracchio","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/glia.20160","article-title":"Metabotropic P2 receptor activation regulates oligodendrocyte progenitor migration and development","volume":"50","author":"Agresti","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.brainresrev.2004.12.005","article-title":"ATP regulates oligodendrocyte progenitor migration, proliferation, and differentiation: involvement of metabotropic P2 receptors","volume":"48","author":"Agresti","year":"2005","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1750-3639.2007.00112.x","article-title":"Up-regulation of adenosine receptors in the frontal cortex in Alzheimer's disease","volume":"18","author":"Albasanz","year":"2008","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib7","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/cercor\/bhp193","article-title":"P2Y12 receptor protein in cortical gray matter lesions in multiple sclerosis","volume":"20","author":"Amadio","year":"2010","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib8","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1471-4159.2010.07025.x","article-title":"Purinergic signalling at the plasma membrane: a multipurpose and multidirectional mode to deal with amyotrophic lateral sclerosis and multiple sclerosis","volume":"116","author":"Amadio","year":"2011","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.nbd.2006.08.018","article-title":"Ivermectin inhibits AMPA receptor-mediated excitotoxicity in cultured motor neurons and extends the life span of a transgenic mouse model of amyotrophic lateral sclerosis","volume":"25","author":"Andries","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib10","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1750-3639.2003.tb00475.x","article-title":"A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation","volume":"13","author":"Angulo","year":"2003","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib11","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S1474-4422(14)70153-X","article-title":"Adenosine A2A receptor antagonists in Parkinson's disease: still in the running","volume":"13","author":"Antonini","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib12","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1093\/hmg\/ddt259","article-title":"Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis","volume":"22","author":"Apolloni","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib13","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1242\/dmm.017038","article-title":"Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis","volume":"7","author":"Apolloni","year":"2014","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib14","doi-asserted-by":"crossref","first-page":"19138","DOI":"10.1073\/pnas.0505913102","article-title":"P2Y2 receptor activates nerve growth factor\/TrkA signaling to enhance neuronal differentiation","volume":"102","author":"Arthur","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib15","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1523\/JNEUROSCI.5338-05.2006","article-title":"Inhibition of apoptosis by P2Y2 receptor activation: novel pathways for neuronal survival","volume":"26","author":"Arthur","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib16","first-page":"771","article-title":"Adenosine A2A receptor antagonists as novel anti-Parkinsonian agents: a review of structure-activity relationships","volume":"64","author":"Azam","year":"2009","journal-title":"Pharmazie"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib17","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.1523\/JNEUROSCI.17-14-05297.1997","article-title":"ATP P2X receptors mediate fast synaptic transmission in the dorsal horn of the rat spinal cord","volume":"17","author":"Bardoni","year":"1997","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib18","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1124\/pr.113.008003","article-title":"The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease","volume":"66","author":"Bartlett","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib19","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1471-4159.2005.03169.x","article-title":"Regional and subtype selective changes of neurotransmitter receptor density in a rat transgenic for the Huntington's disease mutation","volume":"94","author":"Bauer","year":"2005","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib20","doi-asserted-by":"crossref","first-page":"13486","DOI":"10.1073\/pnas.96.23.13486","article-title":"Inosine stimulates extensive axon collateral growth in the rat corticospinal tract after injury","volume":"96","author":"Benowitz","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib21","first-page":"41","article-title":"A\u00a0purine-sensitive mechanism regulates the molecular program for axon growth","volume":"19","author":"Benowitz","year":"2001","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11010-014-1967-9","article-title":"Role of P2X7 purinoceptors in neuroprotective mechanism of ischemic postconditioning in mice","volume":"390","author":"Bindra","year":"2014","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.neuroscience.2010.06.063","article-title":"The cortical stab injury induces beading of fibers expressing ecto-nucleoside triphosphate diphosphohydrolase 3","volume":"170","author":"Bjelobaba","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib24","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/jnr.22599","article-title":"Dynamic changes in the expression pattern of ecto-5\u2032-nucleotidase in the rat model of cortical stab injury","volume":"89","author":"Bjelobaba","year":"2011","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib25","doi-asserted-by":"crossref","first-page":"16284","DOI":"10.1523\/JNEUROSCI.2590-10.2010","article-title":"Quantification of indirect pathway inhibition by the adenosine A2a antagonist SYN115 in Parkinson disease","volume":"30","author":"Black","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib26","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1097\/00001756-199408150-00015","article-title":"Distribution of [3H]\u03b1,\u03b2-methylene ATP binding sites in rat brain and spinal cord","volume":"5","author":"Bo","year":"1994","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib27","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1182\/blood-2006-12-064527","article-title":"Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression","volume":"110","author":"Borsellino","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib28","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nm0508-483","article-title":"Assessing fetal nerve cell grafts in Parkinson's disease","volume":"14","author":"Braak","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib29","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/sj.bjp.0702333","article-title":"Cyclo-oxygenase-2 mediates P2Y receptor-induced reactive astrogliosis","volume":"126","author":"Brambilla","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib30","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1523\/JNEUROSCI.18-13-04891.1998","article-title":"Upregulation of the enzyme chain hydrolyzing extracellular ATP after transient forebrain ischemia in the rat","volume":"18","author":"Braun","year":"1998","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jneuroim.2005.05.012","article-title":"Purinergic receptor modulation of BV-2 microglial cell activity: potential involvement of p38 MAP kinase and CREB","volume":"166","author":"Brautigam","year":"2005","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib32","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0306-4522(96)00156-X","article-title":"Central noradrenergic neurons signal via ATP to elicit vasopressin responses to haemorrhage","volume":"73","author":"Buller","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib33","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0031-6997(25)06930-3","article-title":"Purinergic nerves","volume":"24","author":"Burnstock","year":"1972","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0306-4522(76)90054-3","article-title":"Do some nerve cells release more than one transmitter?","volume":"1","author":"Burnstock","year":"1976","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib35","series-title":"Cell Membrane Receptors for Drugs and Hormones: a Multidisciplinary Approach","first-page":"107","article-title":"A\u00a0basis for distinguishing two types of purinergic receptor","author":"Burnstock","year":"1978"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/smns.1996.0022","article-title":"(Guest Editor). Purinergic neurotransmission","volume":"8","author":"Burnstock","year":"1996","journal-title":"Semin. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib37","first-page":"335","article-title":"Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction","volume":"194","author":"Burnstock","year":"1999","journal-title":"J.\u00a0Anat."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib38","series-title":"Current Topics in Membranes","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1063-5823(03)01010-X","article-title":"Purinergic receptors in the nervous system","volume":"vol. 54","author":"Burnstock","year":"2003"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib39","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00018-007-6497-0","article-title":"Purine and pyrimidine receptors","volume":"64","author":"Burnstock","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib40","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1152\/physrev.00043.2006","article-title":"Physiology and pathophysiology of purinergic neurotransmission b","volume":"87","author":"Burnstock","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib41","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrd2605","article-title":"Purinergic signalling and disorders of the central nervous system","volume":"7","author":"Burnstock","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1062798713000586","article-title":"The Erasmus Lecture 2012, Academia Europaea. The concept of cotransmission: focus on ATP as a cotransmitter and its significance in health and disease","volume":"22","author":"Burnstock","year":"2014","journal-title":"Eur. Rev."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib43","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2174\/0929867321666140706130415","article-title":"Physiopathological roles of P2X receptors in the central nervous system","volume":"22","author":"Burnstock","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib44","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0074-7696(04)40002-3","article-title":"Cellular distribution and functions of P2 receptor subtypes in different systems","volume":"240","author":"Burnstock","year":"2004","journal-title":"Int. Rev. Cytol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib45","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s00018-010-0614-1","article-title":"Purinergic signalling in embryonic and stem cell development","volume":"68","author":"Burnstock","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib46","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1038\/cddis.2009.11","article-title":"Long-term (trophic) purinergic signalling: purinoceptors control cell proliferation, differentiation and death","volume":"1","author":"Burnstock","year":"2010","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib47","series-title":"Purinergic Signalling and the Nervous System","author":"Burnstock","year":"2012"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib48","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2174\/156802611795347627","article-title":"Adenosine and ATP receptors in the brain","volume":"11","author":"Burnstock","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib49","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10143-002-0233-x","article-title":"Acute phase effects of ATP-MgCl2 on experimental spinal cord injury","volume":"26","author":"Cakir","year":"2003","journal-title":"Neurosurg. Rev."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib50","doi-asserted-by":"crossref","first-page":"18696","DOI":"10.1074\/jbc.M500219200","article-title":"P2Y2 nucleotide receptors enhance \u03b1-secretase-dependent amyloid precursor protein processing","volume":"280","author":"Camden","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib51","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/cne.21527","article-title":"Strong P2X4 purinergic receptor-like immunoreactivity is selectively associated with degenerating neurons in transgenic rodent models of amyotrophic lateral sclerosis","volume":"506","author":"Casanovas","year":"2008","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib52","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1067\/mva.2001.117996","article-title":"An adenosine A2A agonist, ATL-146e, reduces paralysis and apoptosis during rabbit spinal cord reperfusion","volume":"34","author":"Cassada","year":"2001","journal-title":"J.\u00a0Vasc. Surg."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib53","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/brain\/awp147","article-title":"The P2Y-like receptor GPR17 as a sensor of damage and a new potential target in spinal cord injury","volume":"132","author":"Ceruti","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib54","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/glia.21107","article-title":"Expression of the new P2Y-like receptor GPR17 during oligodendrocyte precursor cell maturation regulates sensitivity to ATP-induced death","volume":"59","author":"Ceruti","year":"2011","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib55","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1002\/jnr.21071","article-title":"Activation of adenosine A3 receptors reduces ischemic brain injury in rodents","volume":"84","author":"Chen","year":"2006","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib56","doi-asserted-by":"crossref","first-page":"9192","DOI":"10.1523\/JNEUROSCI.19-21-09192.1999","article-title":"A2A adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice","volume":"19","author":"Chen","year":"1999","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib57","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.pneurobio.2007.09.002","article-title":"Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and \u201cfine tuning\u201d modulation","volume":"83","author":"Chen","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib58","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.4049\/jimmunol.176.5.3115","article-title":"Exacerbation of experimental autoimmune encephalomyelitis in P2X7R-\/- mice: evidence for loss of apoptotic activity in lymphocytes","volume":"176","author":"Chen","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib59","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/nn.2410","article-title":"The oligodendrocyte-specific G protein-coupled receptor GPR17 is a cell-intrinsic timer of myelination","volume":"12","author":"Chen","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib60","first-page":"15","article-title":"Agonists of the A2A adenosine receptor protect neurons derived from induced pluripotent stem cells of patients with Huntington's disease","volume":"130","author":"Chern","year":"2014","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib61","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/brain\/aws286","article-title":"Antagonism of purinergic signalling improves recovery from traumatic brain injury","volume":"136","author":"Choo","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib62","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1471-4159.2004.02699.x","article-title":"P2Y2 receptors activate neuroprotective mechanisms in astrocytic cells","volume":"91","author":"Chorna","year":"2004","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib63","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/glia.440070207","article-title":"Stimulation of astrocyte proliferation by purine and pyrimidine nucleotides and nucleosides","volume":"7","author":"Christjanson","year":"1993","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib64","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.bbamem.2011.02.007","article-title":"Adenosine receptor containing oligomers: their role in the control of dopamine and glutamate neurotransmission in the brain","volume":"1808","author":"Ciruela","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib65","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/jamaneurol.2014.3558","article-title":"Inflammation and neuroprotection in traumatic brain injury","volume":"72","author":"Corps","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib66","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3233\/JAD-132300","article-title":"Adenosine triphosphate (ATP) reduces amyloid-\u03b2 protein misfolding in\u00a0vitro","volume":"41","author":"Coskuner","year":"2014","journal-title":"J.\u00a0Alzheimers. Dis."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib67","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1523\/JNEUROSCI.20-08-02835.2000","article-title":"ATP-mediated glia signaling","volume":"20","author":"Cotrina","year":"2000","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib68","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0024-3205(00)00923-1","article-title":"ATP as a presynaptic modulator","volume":"68","author":"Cunha","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib69","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.4049\/jimmunol.0901212","article-title":"The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis","volume":"183","author":"D'Ambrosi","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib70","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1523\/JNEUROSCI.5030-06.2007","article-title":"Hypoxia suppresses glutamate transport in astrocytes","volume":"27","author":"Dallas","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib71","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/nn1472","article-title":"ATP mediates rapid microglial response to local brain injury in\u00a0vivo","volume":"8","author":"Davalos","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib72","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1074\/jbc.M110.200618","article-title":"The purinergic receptor P2X7 triggers alpha-secretase-dependent processing of the amyloid precursor protein","volume":"286","author":"Delarasse","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib73","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s11302-010-9206-7","article-title":"Nucleotides affect neurogenesis and dopaminergic differentiation of mouse fetal midbrain-derived neural precursor cells","volume":"6","author":"Delic","year":"2010","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib74","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1096\/fj.08-122275","article-title":"Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration","volume":"23","author":"D\u00edaz-Hern\u00e1ndez","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib75","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/glia.20958","article-title":"P2X7 receptors mediate ischemic damage to oligodendrocytes","volume":"58","author":"Domercq","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib76","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0074-7742(08)60556-5","article-title":"The physiological role of adenosine in the central nervous system","volume":"27","author":"Dunwiddie","year":"1985","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib77","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/359144a0","article-title":"ATP receptor-mediated synaptic currents in the central nervous system","volume":"359","author":"Edwards","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib78","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1056\/NEJMra1205750","article-title":"Purinergic signaling during inflammation","volume":"367","author":"Eltzschig","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/boc.201400043","article-title":"P2Y receptors in Alzheimer's disease","volume":"107","author":"Erb","year":"2015","journal-title":"Biol. Cell."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib80","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1002\/glia.22722","article-title":"White matter injury: Ischemic and nonischemic","volume":"62","author":"Fern","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib81","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3389\/fncel.2014.00260","article-title":"The two-hit hypothesis for neuroinflammation: role of exogenous ATP in modulating inflammation in the brain","volume":"8","author":"Fiebich","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib82","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrn1928","article-title":"Purinergic signaling in neuron-glial interactions","volume":"7","author":"Fields","year":"2006","journal-title":"Nat. Neurosci. Rev."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib83","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1126\/science.298.5593.556","article-title":"New insights into neuron-glia communication","volume":"298","author":"Fields","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib84","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0306-4522(02)00397-4","article-title":"Cerebellar lesion up-regulates P2X1 and P2X2 purinergic receptors in precerebellar nuclei","volume":"115","author":"Florenzano","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib85","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0306-4522(01)00416-X","article-title":"P2X receptor expression on astrocytes in the nucleus accumbens of rats","volume":"108","author":"Franke","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib86","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/jnen\/63.7.686","article-title":"P2X7 receptor expression after ischemia in the cerebral cortex of rats","volume":"63","author":"Franke","year":"2004","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib87","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.neuroscience.2004.05.003","article-title":"P2Y receptor expression on astrocytes in the nucleus accumbens of rats","volume":"127","author":"Franke","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib88","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.pharmthera.2005.06.002","article-title":"Involvement of P2 receptors in the growth and survival of neurons in the CNS","volume":"109","author":"Franke","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib89","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s00424-006-0071-8","article-title":"P2 receptors and neuronal injury","volume":"452","author":"Franke","year":"2006","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib90","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijdevneu.2005.11.016","article-title":"Changes in purinergic signaling after cerebral injury - involvement of glutamatergic mechanisms?","volume":"24","author":"Franke","year":"2006","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib91","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11302-007-9082-y","article-title":"Involvement of P2X and P2Y receptors in microglial activation in\u00a0vivo","volume":"3","author":"Franke","year":"2007","journal-title":"Purinergic. Signal."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11302-011-9225-z","article-title":"Role of G protein-coupled receptors (GPCRs) for purines and pyrimidines in mediating degeneration and regeneration under neuroinflammatory processes","volume":"7","author":"Franke","year":"2011","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib93","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s11302-013-9366-3","article-title":"Changes of the GPR17 receptor, a new target for neurorepair, in neurons and glial cells in patients with traumatic brain injury","volume":"9","author":"Franke","year":"2013","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib94","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1113\/jphysiol.1987.sp016447","article-title":"Effects of hypoxia on rat hippocampal neurones in\u00a0vitro","volume":"384","author":"Fujiwara","year":"1987","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib95","doi-asserted-by":"crossref","first-page":"10593","DOI":"10.1074\/jbc.M110.162867","article-title":"Phenotypic changes, signaling pathway and functional correlates of GPR17-expressing neural precursor cells during oligodendrocyte differentiation","volume":"286","author":"Fumagalli","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib96","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1742-2094-7-33","article-title":"Extracellular ATP and the P2X7 receptor in astrocyte-mediated motor neuron death: implications for amyotrophic lateral sclerosis","volume":"7","author":"Gandelman","year":"2010","journal-title":"J.\u00a0Neuroinflammation."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib97","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0197-0186(95)00137-9","article-title":"Both adenosine A1- and A2-receptors are required to stimulate microglial proliferation","volume":"29","author":"Gebicke-Haerter","year":"1996","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib98","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/sj.cdd.4402144","article-title":"Glia: the fulcrum of brain diseases","volume":"14","author":"Giaume","year":"2007","journal-title":"Cell. Death. Differ."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib99","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1006\/smns.1996.0029","article-title":"Fast purinergic transmission in the central nervous system","volume":"8","author":"Gibb","year":"1996","journal-title":"Semin. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib100","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1478-811X-11-12","article-title":"Implications of purinergic receptor-mediated intracellular calcium transients in neural differentiation","volume":"11","author":"Glaser","year":"2013","journal-title":"Cell. Commun. Signal"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib101","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.bbamem.2010.12.001","article-title":"Adenosine receptors and brain diseases: neuroprotection and neurodegeneration","volume":"1808","author":"Gomes","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib102","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1523\/JNEUROSCI.3763-04.2005","article-title":"Release of ATP in the ventral medulla during hypoxia in rats: role in hypoxic ventilatory response","volume":"25","author":"Gourine","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib103","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1126\/science.1190721","article-title":"Astrocytes control breathing through pH-dependent release of ATP","volume":"329","author":"Gourine","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib104","doi-asserted-by":"crossref","first-page":"65","DOI":"10.55782\/ane-2011-1823","article-title":"Expression of purinergic P2X7 receptor in rat brain during the symptomatic phase of experimental autoimmune encephalomyelitis and after recovery of neurological deficits","volume":"71","author":"Grygorowicz","year":"2011","journal-title":"Acta Neurobiol. Exp. (Wars.)"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib105","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.neuroscience.2004.06.073","article-title":"Cooperation in signal transduction of extracellular guanosine 5' triphosphate and nerve growth factor in neuronal differentiation of PC12 cells","volume":"128","author":"Guarnieri","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib106","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neuroscience.2005.04.026","article-title":"Lesional accumulation of P2X4 receptor+ macrophages in rat CNS during experimental autoimmune encephalomyelitis","volume":"134","author":"Guo","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib107","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.neuroscience.2008.07.062","article-title":"Expression of P2X5 receptors in the mouse central nervous system","volume":"156","author":"Guo","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib108","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.nbd.2014.03.004","article-title":"Adenosine A2A receptor antagonism reverses inflammation-induced impairment of microglial process extension in a model of Parkinson's disease","volume":"67","author":"Gyoneva","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib109","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0306-4522(99)00588-6","article-title":"Extracellular guanosine 5' triphosphate enhances nerve growth factor-induced neurite outgrowth via increases in intracellular calcium","volume":"96","author":"Gysbers","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib110","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/NEN.0b013e3181cd3e33","article-title":"Neurotoxic species of misfolded SOD1G93A recognized by antibodies against the P2X4 subunit of the ATP receptor accumulate in damaged neurons of transgenic animal models of amyotrophic lateral sclerosis","volume":"69","author":"Hern\u00e1ndez","year":"2010","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib111","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0736-5748(96)00020-2","article-title":"Neurite outgrowth of striatal neurons in\u00a0vitro: involvement of purines in the growth promoting effect of myenteric plexus explants","volume":"14","author":"H\u00f6pker","year":"1996","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib112","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1750-1326-6-28","article-title":"Lack of neuroprotection in the absence of P2X7 receptors in toxin-induced animal models of Parkinson's disease","volume":"6","author":"Hracsk\u00f3","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib113","doi-asserted-by":"crossref","first-page":"7904","DOI":"10.1073\/pnas.86.20.7904","article-title":"Extracellular ATP is a mitogen for 3T3, 3T6, and A431 cells and acts synergistically with other growth factors","volume":"86","author":"Huang","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib114","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nm.2399","article-title":"The immunology of stroke: from mechanisms to translation","volume":"17","author":"Iadecola","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib115","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nature13085","article-title":"Nucleotide signalling during inflammation","volume":"509","author":"Idzko","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib116","first-page":"1","article-title":"Nucleotides and their receptors in the nervous system","volume":"120","author":"Illes","year":"1999","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib117","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/1073858411418524","article-title":"P2X receptors and their role in astroglia in the central and peripheral nervous system","volume":"18","author":"Illes","year":"2012","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib118","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0301-0082(96)00037-8","article-title":"Implication of ATP receptors in brain functions","volume":"50","author":"Inoue","year":"1996","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib119","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1254\/jjp.78.405","article-title":"ATP receptors for the protection of hippocampal functions","volume":"78","author":"Inoue","year":"1998","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib120","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.neuron.2006.02.006","article-title":"Astrocytes promote myelination in response to electrical impulses","volume":"49","author":"Ishibashi","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib121","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0306-4522(90)90246-Z","article-title":"Alzheimer's disease: changes in hippocampal N-methyl-D-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors\u2013an autoradiographic study","volume":"39","author":"Jansen","year":"1990","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib122","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.parkreldis.2008.12.006","article-title":"Adenosine, adenosine A2A antagonists, and Parkinson's disease","volume":"15","author":"Jenner","year":"2009","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib123","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.1523\/JNEUROSCI.22-12-04794.2002","article-title":"Coordinate release of ATP and GABA at in\u00a0vitro synapses of lateral hypothalamic neurons","volume":"22","author":"Jo","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib124","series-title":"ATP-mediated Necrotic Volume Increase (NVI) in Substantia Nigra Pars Compacta Dopaminergic Neuron","first-page":"18","author":"Jun","year":"2004"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib125","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1523\/JNEUROSCI.6357-11.2012","article-title":"Astrocyte-originated ATP protects A\u03b2(1-42)-induced impairment of synaptic plasticity","volume":"32","author":"Jung","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib126","doi-asserted-by":"crossref","first-page":"936891","DOI":"10.1155\/2014\/936891","article-title":"ATP release through lysosomal exocytosis from peripheral nerves: the effect of lysosomal exocytosis on peripheral nerve degeneration and regeneration after nerve injury","volume":"2014","author":"Jung","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib127","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/(SICI)1096-9861(19990428)407:1<11::AID-CNE2>3.0.CO;2-R","article-title":"Distribution of the P2X2 receptor subunit of the ATP-gated ion channels in the rat central nervous system","volume":"407","author":"Kanjhan","year":"1999","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib128","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.nbd.2006.08.020","article-title":"Changes in the expression of P2X1 and P2X2 purinergic receptors in facial motoneurons after nerve lesions in rodents and correlation with motoneuron degeneration","volume":"25","author":"Kassa","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib129","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1254\/jphs.94.107","article-title":"ATP- and adenosine-mediated signaling in the central nervous system: synaptic purinoceptors: the stage for ATP to play its \u201cdual-role\u201d","volume":"94","author":"Kato","year":"2004","journal-title":"J.\u00a0Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib130","doi-asserted-by":"crossref","first-page":"18518","DOI":"10.1074\/jbc.272.30.18518","article-title":"Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells","volume":"272","author":"Kawasaki","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib131","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/35058521","article-title":"Molecular physiology of P2X receptors and ATP signalling at synapses","volume":"2","author":"Khakh","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib132","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00221-002-1251-1","article-title":"Suramin reduces infarct volume in a model of focal brain ischemia in rats","volume":"147","author":"Kharlamov","year":"2002","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib133","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1113\/jphysiol.1995.sp020566","article-title":"Activation of P2-purinoreceptors triggered Ca2+ release from InsP3 -sensitive internal stores in mammalian oligodendrocytes","volume":"483","author":"Kirischuk","year":"1995","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib134","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0006-8993(78)90700-X","article-title":"A\u00a0pictorial representation of endogenous brain ATP by a bioluminescent method","volume":"154","author":"Kogure","year":"1978","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib135","first-page":"375","article-title":"Early effects of hypoxia on brain cell function","volume":"40","author":"Krnjevic","year":"1999","journal-title":"Croat. Med. J."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib136","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/syn.10162","article-title":"Purinergic modulation of neuronal activity in the mesolimbic dopaminergic system in\u00a0vivo","volume":"47","author":"Kr\u00fcgel","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib137","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.brainres.2004.09.044","article-title":"Comparative hydrolysis of extracellular adenine nucleotides and adenosine in synaptic membranes from porcine brain cortex, hippocampus, cerebellum and medulla oblongata","volume":"1030","author":"Kukulski","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib138","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1471-4159.2001.00607.x","article-title":"Adenosine in the central nervous system: release mechanisms and extracellular concentrations","volume":"79","author":"Latini","year":"2001","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib139","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/B978-0-12-385526-8.00008-4","article-title":"Molecular mechanisms of purine and pyrimidine nucleotide release","volume":"61","author":"Lazarowski","year":"2011","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib140","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1111\/j.1460-9568.2006.04825.x","article-title":"Neuroprotective effects of the P2 receptor antagonist PPADS on focal cerebral ischaemia-induced injury in rats","volume":"23","author":"L\u00e4mmer","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib141","doi-asserted-by":"crossref","first-page":"e19983","DOI":"10.1371\/journal.pone.0019983","article-title":"The P2 receptor antagonist PPADS supports recovery from experimental stroke in\u00a0vivo","volume":"6","author":"L\u00e4mmer","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib142","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0014-2999(02)01848-4","article-title":"Extracellular ATP and P2X7 receptors in neurodegeneration","volume":"447","author":"Le Feuvre","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib143","doi-asserted-by":"crossref","first-page":"e3579","DOI":"10.1371\/journal.pone.0003579","article-title":"The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair","volume":"3","author":"Lecca","year":"2008","journal-title":"PLoS. One"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib144","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3858\/emm.2011.43.1.001","article-title":"Microglial P2X receptor expression is accompanied by neuronal damage in the cerebral cortex of the APPswe\/PS1dE9 mouse model of Alzheimer's disease","volume":"43","author":"Lee","year":"2011","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib145","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/j.febslet.2011.05.048","article-title":"Opposite effects of P2X7 and P2Y2 nucleotide receptors on \u03b1-secretase-dependent APP processing in Neuro-2a cells","volume":"585","author":"Le\u00f3n-Otegui","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib146","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ydbio.2006.09.017","article-title":"Purinergic signaling regulates neural progenitor cell expansion and neurogenesis","volume":"302","author":"Lin","year":"2007","journal-title":"Dev. Biol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib147","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neulet.2004.11.075","article-title":"P2 receptor antagonist PPADS confers neuroprotection against glutamate\/NMDA toxicity","volume":"377","author":"Lin","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib148","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1097\/00001756-199808030-00022","article-title":"Ultrastructural localization of P2X3 receptors in rat sensory neurons","volume":"9","author":"Llewellyn-Smith","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib149","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s004410051175","article-title":"Electron-immunocytochemical localization of P2X1 receptors in the rat cerebellum","volume":"294","author":"Loesch","year":"1998","journal-title":"Cell. Tissue Res."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib150","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2174\/157015909789152137","article-title":"Adenosine neuromodulation and traumatic brain injury","volume":"7","author":"Lusardi","year":"2009","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib151","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11302-007-9074-y","article-title":"New insights into purinergic receptor signaling in neuronal differentiation, neuroprotection, and brain disorders","volume":"3","author":"Majumder","year":"2007","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib152","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00702-010-0400-0","article-title":"On the role of P2X7 receptors in dopamine nerve cell degeneration in a rat model of Parkinson's disease: studies with the P2X7 receptor antagonist A-438079","volume":"117","author":"Marcellino","year":"2010","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib153","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrn1908","article-title":"The therapeutic potential of neural stem cells","volume":"7","author":"Martino","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib154","series-title":"Handbook of Experimental Pharmacology. Purinergic and Pyrimidinergic Signalling I \u2013 Molecular, Nervous and Urinogenitary System Function","first-page":"251","article-title":"Role of purines and pyrimidines in the central nervous system","author":"Masino","year":"2001"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib155","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1254\/jphs.94.95","article-title":"ATP- and adenosine-mediated signaling in the central nervous system: adenosine receptor activation by ATP through rapid and localized generation of adenosine by ecto-nucleotidases","volume":"94","author":"Matsuoka","year":"2004","journal-title":"J.\u00a0Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib156","doi-asserted-by":"crossref","first-page":"9525","DOI":"10.1523\/JNEUROSCI.0579-07.2007","article-title":"P2X7 receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis","volume":"27","author":"Matute","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib157","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.semcdb.2011.02.011","article-title":"Neuroglial interactions mediated by purinergic signalling in the pathophysiology of CNS disorders","volume":"22","author":"Matute","year":"2011","journal-title":"Semin. Cell. Dev. Biol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib158","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1097\/01.jnen.0000240470.97295.d3","article-title":"Upregulated expression of purinergic P2X7 receptor in Alzheimer disease and amyloid-\u03b2 peptide-treated microglia and in peptide-injected rat hippocampus","volume":"65","author":"McLarnon","year":"2006","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib159","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.neuint.2005.05.014","article-title":"ATP extracellular concentrations are increased in the rat striatum during in\u00a0vivo ischemia","volume":"47","author":"Melani","year":"2005","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib160","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/sj.jcbfm.9600250","article-title":"P2X7 receptor modulation on microglial cells and reduction of brain infarct caused by middle cerebral artery occlusion in rat","volume":"26","author":"Melani","year":"2006","journal-title":"J.\u00a0Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib161","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neuroscience.2004.03.031","article-title":"ATP-induced inhibition of gap junctional communication is enhanced by interleukin-1 beta treatment in cultured astrocytes","volume":"126","author":"M\u00eame","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib162","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1874082020130807001","article-title":"Co-expression of functional P2X4 and P2X7 receptors at adult neural progenitor cells of the mouse subventricular zone","volume":"7","author":"Messemer","year":"2013","journal-title":"Open Neurosci. J."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib163","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neuropharm.2013.05.017","article-title":"P2X7 receptors at adult neural progenitor cells of the mouse subventricular zone","volume":"73","author":"Messemer","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib164","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.nbd.2011.03.006","article-title":"Worsening of Huntington disease phenotype in CB1 receptor knockout mice","volume":"43","author":"Mievis","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib165","first-page":"1127","article-title":"Physiological role of extracellular nucleotides at the central nervous system: signalling through P2X and P2Y receptors","volume":"73","author":"Miras-Portugal","year":"2007","journal-title":"An. R. Acad. Nac. Farm."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib166","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1242\/dev.02233","article-title":"Extracellular nucleotide signaling in adult neural stem cells: synergism with growth factor-mediated cellular proliferation","volume":"133","author":"Mishra","year":"2006","journal-title":"Development"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib167","doi-asserted-by":"crossref","first-page":"9250","DOI":"10.1523\/JNEUROSCI.1856-06.2006","article-title":"Protecting motor neurons from toxic insult by antagonism of adenosine A2a and Trk receptors","volume":"26","author":"Mojsilovic-Petrovic","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib168","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1097\/00001756-199812010-00034","article-title":"Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats","volume":"9","author":"Monopoli","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib169","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/(SICI)1096-9861(20000605)421:3<374::AID-CNE6>3.0.CO;2-Z","article-title":"Regional and cellular distribution of the P2Y1 purinergic receptor in the human brain: striking neuronal localisation","volume":"421","author":"Moore","year":"2000","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib170","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0169-328X(00)00067-X","article-title":"Immunohistochemical localization of the P2Y1 purinergic receptor in neurons and glial cells of the central nervous system","volume":"78","author":"Mor\u00e1n-Jim\u00e9nez","year":"2000","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib171","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4103\/2319-4170.127803","article-title":"The role of P2X7 receptor in infectious inflammatory diseases and the influence of ectonucleotidases","volume":"37","author":"Morandini","year":"2014","journal-title":"Biomed. J."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib172","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neuint.2003.11.017","article-title":"Guanine nucleotides inhibit NMDA and kainate-induced neurotoxicity in cultured rat hippocampal and neocortical neurons","volume":"45","author":"Morciano","year":"2004","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib173","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0079-6123(10)83010-9","article-title":"Pathophysiological roles for purines: adenosine, caffeine and urate","volume":"183","author":"Morelli","year":"2010","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib174","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/j.bbamcr.2014.05.004","article-title":"Neuroprotection elicited by P2Y13 receptors against genotoxic stress by inducing DUSP2 expression and MAPK signaling recovery","volume":"1843","author":"Morente","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib175","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1469-7793.2001.t01-1-00115.x","article-title":"Fast synaptic transmission mediated by P2X receptors in CA3 pyramidal cells of rat hippocampal slice cultures","volume":"535","author":"Mori","year":"2001","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib176","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1750-3639.2011.00531.x","article-title":"The neuroprotective effect of a specific P2X7 receptor antagonist derives from its ability to inhibit assembly of the NLRP3 inflammasome in glial cells","volume":"22","author":"Murphy","year":"2012","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib177","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/glia.20110","article-title":"The cytokine IL-1\u03b2 transiently enhances P2X7 receptor expression and function in human astrocytes","volume":"49","author":"Narcisse","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib178","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1046\/j.1471-4159.1994.63020490.x","article-title":"Synergistic activation of DNA synthesis in astrocytes by fibroblast growth factors and extracellular ATP","volume":"63","author":"Neary","year":"1994","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib179","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0166-2236(96)81861-3","article-title":"Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells","volume":"19","author":"Neary","year":"1996","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib180","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1523\/JNEUROSCI.23-06-02348.2003","article-title":"Activation of extracellular signal-regulated kinase by stretch-induced injury in astrocytes involves extracellular ATP and P2 purinergic receptors","volume":"23","author":"Neary","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib181","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1089\/neu.2005.22.491","article-title":"Traumatic injury activates protein kinase B\/Akt in cultured astrocytes: role of extracellular ATP and P2 purinergic receptors","volume":"22","author":"Neary","year":"2005","journal-title":"J.\u00a0Neurotrauma"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib182","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1385\/MN:31:1-3:095","article-title":"Signaling from P2 nucleotide receptors to protein kinase cascades induced by CNS injury: implications for reactive gliosis and neurodegeneration","volume":"31","author":"Neary","year":"2005","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib183","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/jnr.20969","article-title":"P2 purinergic receptors signal to glycogen synthase kinase-3\u03b2 in astrocytes","volume":"84","author":"Neary","year":"2006","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib184","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/9780470032244.ch11","article-title":"P2 receptor signalling, proliferation of astrocytes, and expression of molecules involved in cell-cell interactions","volume":"276","author":"Neary","year":"2006","journal-title":"Novartis. Found. Symp."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib185","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.tins.2009.01.002","article-title":"Trophic functions of nucleotides in the central nervous system","volume":"32","author":"Neary","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib186","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.cellbi.2006.03.001","article-title":"Up-regulation of ectonucleotidase activity after cortical stab injury in rats","volume":"30","author":"Nedeljkovic","year":"2006","journal-title":"Cell. Biol. Int."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib187","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1113\/jphysiol.1995.sp020788","article-title":"Hypoxic changes in rat locus coeruleus neurons in\u00a0vitro","volume":"486","author":"Nieber","year":"1995","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib188","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/sj.bjp.0701386","article-title":"Role of ATP in fast excitatory synaptic potentials in locus coeruleus neurones of the rat","volume":"122","author":"Nieber","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib189","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0079-6123(08)63563-3","article-title":"Brain hypoxia: effects of ATP and adenosine","volume":"120","author":"Nieber","year":"1999","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib190","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00424-006-0060-y","article-title":"Purinergic transmission in the central nervous system","volume":"452","author":"North","year":"2006","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib191","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0006-8993(03)03028-2","article-title":"Adenosine triphosphate inhibits cytokine release from lipopolysaccharide-activated microglia via P2y receptors","volume":"981","author":"Ogata","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib192","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1098\/rstb.2006.2018","article-title":"Neurodegeneration and cell replacement","volume":"363","author":"Ormerod","year":"2008","journal-title":"Philos. Trans. R. Soc. Lond B Biol. Sci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib193","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0079-6123(08)63559-1","article-title":"ATP receptor-mediated component of the excitatory synaptic transmission in the hippocampus","volume":"120","author":"Pankratov","year":"1999","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib194","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1113\/jphysiol.2002.021956","article-title":"Ionotropic P2X purinoreceptors mediate synaptic transmission in rat pyramidal neurones of layer II\/III of somato-sensory cortex","volume":"542","author":"Pankratov","year":"2002","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib195","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neuroscience.2008.03.076","article-title":"P2X receptors and synaptic plasticity","volume":"158","author":"Pankratov","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib196","doi-asserted-by":"crossref","first-page":"e959","DOI":"10.1038\/cddis.2013.491","article-title":"Dysregulated microRNAs in amyotrophic lateral sclerosis microglia modulate genes linked to neuroinflammation","volume":"4","author":"Parisi","year":"2013","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib197","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainresrev.2009.11.008","article-title":"Gliotransmission: exocytotic release from astrocytes","volume":"63","author":"Parpura","year":"2010","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib198","doi-asserted-by":"crossref","first-page":"13309","DOI":"10.1074\/jbc.M209478200","article-title":"P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease","volume":"278","author":"Parvathenani","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib199","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1179\/016164105X21913","article-title":"The protective effect of adenosine A2A receptor antagonism in cerebral ischemia","volume":"27","author":"Pedata","year":"2005","journal-title":"Neurol. Res."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib200","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11302-007-9085-8","article-title":"The role of ATP and adenosine in the brain under normoxic and ischemic conditions","volume":"3","author":"Pedata","year":"2007","journal-title":"Purinergic. Signal."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib201","series-title":"Neurobiological Studies \u2013 from Genes to Behaviour","first-page":"143","article-title":"Molecular basic of brain injury and repair","author":"Pekovic","year":"2006"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib202","doi-asserted-by":"crossref","first-page":"12489","DOI":"10.1073\/pnas.0902531106","article-title":"Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury","volume":"106","author":"Peng","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib203","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1517\/14656566.2014.903924","article-title":"Two new adenosine receptor antagonists for the treatment of Parkinson's disease: istradefylline versus tozadenant","volume":"15","author":"Perez-Lloret","year":"2014","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib204","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s12035-010-8115-7","article-title":"P2Y2 nucleotide receptor-mediated responses in brain cells","volume":"41","author":"Peterson","year":"2010","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib205","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0301-0082(81)90014-9","article-title":"The role of adenosine and its nucleotides in central synaptic transmission","volume":"16","author":"Phillis","year":"1981","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib206","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11010-015-2347-9","article-title":"Neuroinflammation after neonatal hypoxia-ischemia is associated with alterations in the purinergic system: adenosine deaminase 1 isoenzyme is the most predominant after insult","volume":"403","author":"Pimentel","year":"2015","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib207","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1517\/13543780903241615","article-title":"Novel investigational adenosine A2A receptor antagonists for Parkinson's disease","volume":"18","author":"Pinna","year":"2009","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib208","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0306-4522(00)00529-7","article-title":"Co-transmitter function of ATP in central catecholaminergic neurons of the rat","volume":"102","author":"Poelchen","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib209","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0014-2999(95)00679-6","article-title":"Adenosine A2A recerptor stimulation enhances striatal extracellular glutamate levels in rats","volume":"287","author":"Popoli","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib210","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1212\/01.WNL.0000095216.89483.A2","article-title":"Modulation of glutamate release and excitotoxicity by adenosine A2A receptors","volume":"61","author":"Popoli","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib211","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.pneurobio.2006.12.005","article-title":"Functions, dysfunctions and possible therapeutic relevance of adenosine A2A receptors in Huntington's disease","volume":"81","author":"Popoli","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib212","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.2174\/138161208784480117","article-title":"A\u00a0critical evaluation of adenosine A2A receptors as potentially \u201cdruggable\u201d targets in Huntington's disease","volume":"14","author":"Popoli","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib213","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/0306-4522(80)90207-9","article-title":"Release of adenosine 5'-triphosphate from synaptosomes from different regions of rat brain","volume":"5","author":"Potter","year":"1980","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib214","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0031-6997(24)01373-5","article-title":"Receptors for purines and pyrimidines","volume":"50","author":"Ralevic","year":"1998","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib215","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0301-0082(99)00017-9","article-title":"Trophic effects of purines in neurons and glial cells","volume":"59","author":"Rathbone","year":"1999","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib216","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jss.2004.04.006","article-title":"Adenosine A2A analogue reduces long-term neurologic injury after blunt spinal trauma","volume":"121","author":"Reece","year":"2004","journal-title":"J.\u00a0Surg. Res."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib217","first-page":"387","article-title":"Fine tuning neuromodulation by adenosine and neuroprotection","volume":"74","author":"Ribeiro","year":"2008","journal-title":"An. R. Acad. Nac. Farm."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib218","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0301-0082(02)00155-7","article-title":"Adenosine receptors in the nervous system: pathophysiological implications","volume":"68","author":"Ribeiro","year":"2003","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib219","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0959-4388(00)00222-1","article-title":"Synaptic P2X receptors","volume":"11","author":"Robertson","year":"2001","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib220","doi-asserted-by":"crossref","first-page":"6286","DOI":"10.1523\/JNEUROSCI.0628-05.2005","article-title":"Dual presynaptic control by ATP of glutamate release via facilitatory P2X1, P2X2\/3, and P2X3 and inhibitory P2Y1, P2Y2, and\/or P2Y4 receptors in the rat hippocampus","volume":"25","author":"Rodrigues","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib221","doi-asserted-by":"crossref","first-page":"11315","DOI":"10.1523\/JNEUROSCI.23-36-11315.2003","article-title":"Pivotal role of nucleotide P2X2 receptor subunit mediating ventilatory responses to hypoxia: knockout mouse studies","volume":"23","author":"Rong","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib222","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/jnr.10507","article-title":"Adenosine triphosphate induces proliferation of human neural stem cells: role of calcium and p70 ribosomal protein S6 kinase","volume":"72","author":"Ryu","year":"2003","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib223","doi-asserted-by":"crossref","DOI":"10.1097\/WNR.0b013e3283179333","article-title":"Block of purinergic P2X7 receptor is neuroprotective in an animal model of Alzheimer's disease","volume":"19","author":"Ryu","year":"2008","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib224","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.4049\/jimmunol.0803612","article-title":"Activation of microglia by amyloid \u03b2 requires P2X7 receptor expression","volume":"182","author":"Sanz","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib225","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/00001756-199504190-00028","article-title":"Trophic actions of 2-chloroadenosine and bFGF on cultured myenteric neurones","volume":"6","author":"Sch\u00e4fer","year":"1995","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib226","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.bbrc.2008.01.054","article-title":"ATP release by way of connexin 36 hemichannels mediates ischemic tolerance in\u00a0vitro","volume":"368","author":"Schock","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib227","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/978-3-540-89615-9_16","article-title":"Adenosine receptors and the central nervous system","author":"Sebasti\u00e3o","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib228","first-page":"466","article-title":"Recent progress in the discovery of adenosine A2A receptor antagonists for the treatment of Parkinson's disease","volume":"13","author":"Shah","year":"2010","journal-title":"Curr. Opin. Drug Discov. Develop."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib229","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1742-2094-5-33","article-title":"P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis","volume":"5","author":"Sharp","year":"2008","journal-title":"J.\u00a0Neuroinflammation."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib230","series-title":"Treatment of Spinal Cord Injury via Topical Perfusion with an ATP Solution","author":"Shields","year":"2004"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib231","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1182\/blood.V98.8.2412","article-title":"Identification of a candidate human neurohematopoietic stem-cell population","volume":"98","author":"Shih","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib232","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1196\/annals.1403.002","article-title":"The brain as a target for inflammatory processes and neuroprotective strategies","volume":"1122","author":"Skaper","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib233","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2174\/187152711794488638","article-title":"Ion channels on microglia: therapeutic targets for neuroprotection","volume":"10","author":"Skaper","year":"2011","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib234","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev.ne.08.030185.000535","article-title":"Adenosine as a neuromodulator","volume":"8","author":"Snyder","year":"1985","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib235","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s11064-006-9039-5","article-title":"Apyrase and 5'-nucleotidase activities in synaptosomes from the cerebral cortex of rats experimentally demyelinated with ethidium bromide and treated with interferon-\u03b2","volume":"31","author":"Spanevello","year":"2006","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib236","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.tips.2014.08.002","article-title":"P2X7 receptor: an emerging target in central nervous system diseases","volume":"35","author":"Sperl\u00e1gh","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib237","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0306-4522(97)00306-0","article-title":"Co-release of endogenous ATP and [3H]noradrenaline from rat hypothalamic slices: origin and modulation by \u03b12-adrenoceptors","volume":"82","author":"Sperl\u00e1gh","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib238","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neuroscience.2007.07.035","article-title":"Purinergic modulation of glutamate release under ischemic-like conditions in the hippocampus","volume":"149","author":"Sperl\u00e1gh","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib239","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1179\/016164105X21896","article-title":"Adenosine, neurodegeneration and neuroprotection","volume":"27","author":"Stone","year":"2005","journal-title":"Neurol. Res."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib240","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/978-3-540-89615-9_17","article-title":"Adenosine receptors and neurological disease: neuroprotection and neurodegeneration","author":"Stone","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib241","first-page":"101","article-title":"Adenosine triphosphate promotes locomotor recovery after spinal cord injury by activating mammalian target of rapamycin pathway in rats","volume":"8","author":"Sun","year":"2013","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib242","doi-asserted-by":"crossref","first-page":"9238","DOI":"10.1523\/JNEUROSCI.4001-11.2012","article-title":"Purinergic signaling promotes proliferation of adult mouse subventricular zone cells","volume":"32","author":"Suyama","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib243","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1523\/JNEUROSCI.3792-03.2004","article-title":"Production and release of neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia","volume":"24","author":"Suzuki","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib244","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00005-010-0069-y","article-title":"P2X7 receptor signaling pathway as a therapeutic target for neurodegenerative diseases","volume":"58","author":"Takenouchi","year":"2010","journal-title":"Arch. Immunol. Ther. Exp. (Warsz.)"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib245","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.nbd.2006.01.014","article-title":"Early and transient alteration of adenosine A2A receptor signaling in a mouse model of Huntington disease","volume":"23","author":"Tarditi","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib246","first-page":"311","article-title":"Implantation of the myenteric plexus into the corpus striatum of adult rats: survival of the neurones and glia and interactions with host brain","volume":"4","author":"Tew","year":"1992","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib247","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF00327773","article-title":"Progressive reorganization of the myenteric plexus during one year following reanastomosis of the ileum of the guinea pig","volume":"277","author":"Tokui","year":"1994","journal-title":"Cell. Tissue Res."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib248","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1111\/j.1460-9568.2011.07667.x","article-title":"P2 receptor antagonists prevent synaptic failure and extracellular signal-regulated kinase1\/2 activation induced by oxygen and glucose deprivation in rat CA1 hippocampus in\u00a0vitro","volume":"33","author":"Traini","year":"2011","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib249","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neulet.2011.01.078","article-title":"P2 receptor stimulation induces amyloid precursor protein production and secretion in rat cortical astrocytes","volume":"492","author":"Tran","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib250","doi-asserted-by":"crossref","first-page":"9321","DOI":"10.1073\/pnas.0603146103","article-title":"Purinergic signaling induces thrombospondin-1 expression in astrocytes","volume":"103","author":"Tran","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib251","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/cyto.a.20666","article-title":"Novel perspectives of neural stem cell differentiation: from neurotransmitters to therapeutics","volume":"75","author":"Trujillo","year":"2009","journal-title":"Cytom. A"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib252","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/nature01786","article-title":"P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury","volume":"424","author":"Tsuda","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib253","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0306-4522(93)90533-L","article-title":"Reduced density of adenosine A1 receptors and preserved coupling of adenosine A1 receptors to G proteins in Alzheimer hippocampus: a quantitative autoradiographic study","volume":"52","author":"Ulas","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib254","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s12015-012-9372-9","article-title":"Extrinsic purinergic regulation of neural stem\/progenitor cells: implications for CNS development and repair","volume":"8","author":"Ulrich","year":"2012","journal-title":"Stem Cell. Revs Rep."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib256","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3233\/JAD-2011-110350","article-title":"Anti-ATP synthase autoantibodies from patients with Alzheimer's disease reduce extracellular HDL level","volume":"26","author":"Vacirca","year":"2011","journal-title":"J.\u00a0Alzheimers. Dis."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib291","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.neurobiolaging.2010.05.013","article-title":"Autoantibodies to the adenosine triphosphate synthase play a pathogenetic role in Alzheimer's disease","volume":"33","author":"Vacirca","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib257","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1096\/fj.00-0730fje","article-title":"Aberrant amplification of A2A receptor signaling in striatal cells expressing mutant huntingtin","volume":"15","author":"Varani","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib258","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.nbd.2007.03.011","article-title":"Biological abnormalities of peripheral A2A receptors in a large representation of polyglutamine disorders and Huntington's disease stages","volume":"27","author":"Varani","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib259","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12017-009-8073-2","article-title":"Amyloid-\u03b2 induces a caspase-mediated cleavage of P2X4 to promote purinotoxicity","volume":"11","author":"Varma","year":"2009","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib260","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.brainresrev.2010.04.007","article-title":"ATP in neuron-glia bidirectional signalling","volume":"66","author":"Verderio","year":"2011","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib261","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s12035-009-8063-2","article-title":"Purinoceptors in neuroglia","volume":"39","author":"Verkhratsky","year":"2009","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib262","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.nbd.2014.05.030","article-title":"Increased striatal adenosine A2A receptor levels is an early event in Parkinson's disease-related pathology and it is potentially regulated by miR-34b","volume":"69","author":"Villar-Men\u00e9ndez","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib263","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1002\/eji.201343314","article-title":"Multiple sclerosis lymphocytes upregulate A2A adenosine receptors that are antiinflammatory when stimulated","volume":"43","author":"Vincenzi","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib264","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.neuroscience.2003.09.030","article-title":"Axotomy dependent purinergic and nitrergic co-expression","volume":"123","author":"Viscomi","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib265","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/1568007033482643","article-title":"Extracellular ATP and neurodegeneration","volume":"2","author":"Volont\u00e9","year":"2003","journal-title":"Curr. Drug Targets CNS. Neurol. Disord."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib266","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2174\/187152712803581119","article-title":"Editorial: pharmacology and therapeutic activity of purinergic drugs for disorders of the nervous system","volume":"11","author":"Volont\u00e9","year":"2012","journal-title":"CNS Neurol. Disorders-Drug Targets"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib267","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0014-2999(94)90523-1","article-title":"Adenosine A3 receptor stimulation and cerebral ischemia","volume":"263","author":"Von Lubitz","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib268","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0014-2999(95)00498-X","article-title":"Cerebral ischemia in gerbils: effects of acute and chronic treatment with adenosine A2A receptor agonist and antagonist","volume":"287","author":"Von Lubitz","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib269","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1113\/jphysiol.2006.126417","article-title":"Auto-inhibition of rat parallel fibre-Purkinje cell synapses by activity-dependent adenosine release","volume":"581","author":"Wall","year":"2007","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib270","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/glia.10004","article-title":"Activation of P2X7 receptors induced [3H]GABA release from the RBA-2 type-2 astrocyte cell line through a Cl-\/HCO3--dependent mechanism","volume":"37","author":"Wang","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib271","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/glia.20758","article-title":"Downregulation of P2X7 receptor expression in rat oligodendrocyte precursor cells after hypoxia ischemia","volume":"57","author":"Wang","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib272","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/nm1082","article-title":"P2X7 receptor inhibition improves recovery after spinal cord injury","volume":"10","author":"Wang","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib273","doi-asserted-by":"crossref","first-page":"7958","DOI":"10.1523\/JNEUROSCI.23-21-07958.2003","article-title":"Diadenosine tetraphosphate protects against injuries induced by ischemia and 6-hydroxydopamine in rat brain","volume":"23","author":"Wang","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib274","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/jnr.10790","article-title":"Neuroprotective effect of adenine on purkinje cell survival in rat cerebellar primary cultures","volume":"74","author":"Watanabe","year":"2003","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib275","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3390\/brainsci3020540","article-title":"Stroke neuroprotection: targeting mitochondria","volume":"3","author":"Watts","year":"2013","journal-title":"Brain Sci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib276","series-title":"Handbook of Neurochemistry","first-page":"1","article-title":"Mammalian central adenosine receptors","author":"Williams","year":"1984"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib277","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/157015909789152209","article-title":"Adenosine and stroke: maximizing the therapeutic potential of adenosine as a prophylactic and acute neuroprotectant","volume":"7","author":"Williams-Karnesky","year":"2009","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib278","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/j.1471-4159.2005.03465.x","article-title":"Supersensitivity of P2X7 receptors in cerebrocortical cell cultures after in\u00a0vitro ischemia","volume":"95","author":"Wirkner","year":"2005","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib279","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s12603-009-0056-3","article-title":"Synapse formation is enhanced by oral administration of uridine and DHA, the circulating precursors of brain phosphatides","volume":"13","author":"Wurtman","year":"2009","journal-title":"J.\u00a0Nutr. Health Aging"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib280","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/jnr.20709","article-title":"Microglial morphology and its transformation after challenge by extracellular ATP in\u00a0vitro","volume":"83","author":"Xiang","year":"2006","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib281","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.plefa.2003.08.016","article-title":"Prostaglandin E2 production in astrocytes: regulation by cytokines, extracellular ATP, and oxidative agents","volume":"69","author":"Xu","year":"2003","journal-title":"Prostagl. Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib282","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/glia.22491","article-title":"Nerve injury induces glial cell line-derived neurotrophic factor (GDNF) expression in Schwann cells through purinergic signaling and the PKC-PKD pathway","volume":"61","author":"Xu","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2015.05.031_bib283","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3109\/10409238.2014.953627","article-title":"Enzymes involved in metabolism of extracellular nucleotides and nucleosides: functional implications and measurement of activities","volume":"49","author":"Yegutkin","year":"2014","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib284","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2377-6-12","article-title":"COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells\/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord","volume":"6","author":"Yiangou","year":"2006","journal-title":"BMC Neurol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib285","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1152\/jn.01166.2005","article-title":"Enhancement of excitatory synaptic transmission in spiny neurons after transient forebrain ischemia","volume":"95","author":"Zhang","year":"2006","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib286","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1021\/cn5000716","article-title":"Optimization of 6-heterocyclic-2-(1H-pyrazol-1-yl)-N-(pyridin-2-yl)pyrimidin-4-amine as potent adenosine A2A receptor antagonists for the treatment of Parkinson's disease","volume":"5","author":"Zheng","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib287","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/0166-2236(94)90016-7","article-title":"Signalling via ATP in the nervous system","volume":"17","author":"Zimmermann","year":"1994","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib288","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s002100000309","article-title":"Extracellular metabolism of ATP and other nucleotides","volume":"362","author":"Zimmermann","year":"2000","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib289","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00424-006-0067-4","article-title":"Nucleotide signaling in nervous system development","volume":"452","author":"Zimmermann","year":"2006","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.neuropharm.2015.05.031_bib290","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0006-8993(00)02781-5","article-title":"Effect of P2 purinoceptor antagonists on kainate-induced currents in rat cultured neurons","volume":"882","author":"Zona","year":"2000","journal-title":"Brain Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815002129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815002129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T11:56:21Z","timestamp":1748433381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390815002129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":290,"alternative-id":["S0028390815002129"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.05.031","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.05.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}